Analysis of MS Patients Who Have Had Greater Than 60 Infusions of Natalizumab
Clinical trial NCT04964700 · UNKNOWN
Trial details
- NCT number
- NCT04964700
- Sponsor
- Multiple Sclerosis Center of Northeastern New York
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-05-06
- Primary completion
- 2022-04-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.